Vaccination Worldwide: Strategies, Distribution and Challenges
Authors:
Chirag Samal,
Kasia Jakimowicz,
Krishnendu Dasgupta,
Aniket Vashishtha,
Francisco O.,
Arunakiry Natarajan,
Haris Nazir,
Alluri Siddhartha Varma,
Tejal Dahake,
Amitesh Anand Pandey,
Ishaan Singh,
John Sangyeob Kim,
Mehrab Singh Gill,
Saurish Srivastava,
Orna Mukhopadhyay,
Parth Patwa,
Qamil Mirza,
Sualeha Irshad,
Sheshank Shankar,
Rohan Iyer,
Rohan Sukumaran,
Ashley Mehra,
Anshuman Sharma,
Abhishek Singh,
Maurizio Arseni
, et al. (4 additional authors not shown)
Abstract:
The Coronavirus 2019 (Covid-19) pandemic caused by the SARS-CoV-2 virus represents an unprecedented crisis for our planet. It is a bane of the über connected world that we live in that this virus has affected almost all countries and caused mortality and economic upheaval at a scale whose effects are going to be felt for generations to come. While we can all be buoyed at the pace at which vaccines…
▽ More
The Coronavirus 2019 (Covid-19) pandemic caused by the SARS-CoV-2 virus represents an unprecedented crisis for our planet. It is a bane of the über connected world that we live in that this virus has affected almost all countries and caused mortality and economic upheaval at a scale whose effects are going to be felt for generations to come. While we can all be buoyed at the pace at which vaccines have been developed and brought to market, there are still challenges ahead for all countries to get their populations vaccinated equitably and effectively. This paper provides an overview of ongoing immunization efforts in various countries. In this early draft, we have identified a few key factors that we use to review different countries' current COVID-19 immunization strategies and their strengths and draw conclusions so that policymakers worldwide can learn from them. Our paper focuses on processes related to vaccine approval, allocation and prioritization, distribution strategies, population to vaccine ratio, vaccination governance, accessibility and use of digital solutions, and government policies. The statistics and numbers are dated as per the draft date [June 24th, 2021].
△ Less
Submitted 21 July, 2021;
originally announced July 2021.
Clinical Landscape of COVID-19 Testing: Difficult Choices
Authors:
Darshan Gandhi,
Sanskruti Landage,
Joseph Bae,
Sheshank Shankar,
Rohan Sukumaran,
Parth Patwa,
Sethuraman T V,
Priyanshi Katiyar,
Shailesh Advani,
Rohan Iyer,
Sunaina Anand,
Aryan Mahindra,
Rachel Barbar,
Abhishek Singh,
Ramesh Raskar
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly across the world, leading to enormous amounts of human death and economic loss. Until definitive preventive or curative measures are developed, policies regarding testing, contact tracing, and quarantine remain the best public health tools for curbing viral spread. Testing is a crucial component of these efforts, enabling the iden…
▽ More
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly across the world, leading to enormous amounts of human death and economic loss. Until definitive preventive or curative measures are developed, policies regarding testing, contact tracing, and quarantine remain the best public health tools for curbing viral spread. Testing is a crucial component of these efforts, enabling the identification and isolation of infected individuals. Differences in testing methodologies, time frames, and outcomes can have an impact on their overall efficiency, usability and efficacy. In this early draft, we draw a comparison between the various types of diagnostic tests including PCR, antigen, and home tests in relation to their relative advantages, disadvantages, and use cases. We also look into alternative and unconventional methods. Further, we analyze the short-term and long-term impacts of the virus and its testing on various verticals such as business, government laws, policies, and healthcare.
△ Less
Submitted 15 November, 2020; v1 submitted 9 November, 2020;
originally announced November 2020.
